GREY:ICOTF - Post by User
Comment by
48thHighlanderon Jun 24, 2018 4:22pm
110 Views
Post# 28221097
RE:The elusive butterfly of love
RE:The elusive butterfly of loveDrHoliday wrote: "Oh, Hoto is going dancing to LaLaland to pick daisies and buttercups and chase elusive PDP butterflies now that he is out of ICO, and then to sow doubt here while pumping up his new play".
It would appear that he himself has forgotten the bullish investment case for ICO, or is he a scalper in reality merely trying to bash ICO lower for a repurchase? If you follow the money, you will realize that the big players did indeed take a profit, but understand the size of the market and how Oral B Amphotericin could be a game changer and challenge Gilead's billion dollar market share for the injectable version which has been around for 50 years. If you think that AstraZeneca has no interest in Oral B, then you are sadly mistaken. I don't know when the US32 million dollar milestone payment option must be paid. It might not be until successful Phase 3 trials. Meanwhile, ICO could easily do a small financing at a premium to the market and close it in a done deal in a heartbeat just to tide them over to continue work and proceed to Phase 2.
Mark my words that AstraZeneca will be watching ICO for phase 1 trial results in July, and taking
an eqity stake in ICO would be a strategic move, and help to defend against any hostility by unfriendly competitors who do not want to lose market share to Oral B Amphotericin.
https://www.youtube.com/watch?v=2JyMGb-d8Io
THIS !!! is what I mean by informed postimg....well done good doctor..well done !!
Place this with a few other very great information/discussion based posts this weekend and a picture emerges....
YES... the CEO would "intimately" know whats going on.in his own fiefdom....
NO.... Astra-Zeneca would not let a multi billion dollar asset go for want of 32 million....